Literature DB >> 17654739

Piercing the armor of hepatobiliary cancer: Bcl-2 homology domain 3 (BH3) mimetics and cell death.

Justin L Mott1, Gregory J Gores.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17654739     DOI： 10.1002/hep.21812

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  13 in total

1.  Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.

Authors:  Nagwa I Abdel-Hamid; Mona F El-Azab; Yasser M Moustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-09       Impact factor: 3.000

Review 2.  Apoptosis in liver carcinogenesis and chemotherapy.

Authors:  Joaquim Moreno-Càceres; Isabel Fabregat
Journal:  Hepat Oncol       Date:  2015-11-11

3.  Curcumin: a unique antioxidant offers a multimechanistic approach for management of hepatocellular carcinoma in rat model.

Authors:  Hanaa H Ahmed; Wafaa Gh Shousha; Aziza B Shalby; Hatem A El-Mezayen; Nora N Ismaiel; Nadia S Mahmoud
Journal:  Tumour Biol       Date:  2014-11-05

4.  Effects of Wnt-1 blockade in DEN-induced hepatocellular adenomas of mice.

Authors:  Argyrios Sklavos; Theofilos Poutahidis; Alexander Giakoustidis; Kali Makedou; Katerina Angelopoulou; Alexander Hardas; Paola Andreani; Argyro Zacharioudaki; George Saridis; Thomas Goulopoulos; Kalliopi Tsarea; Maria Karamperi; Vassilios Papadopoulos; Vassilios Papanikolaou; Apostolos Papalois; Stavros Iliadis; Satvinder Mudan; Daniel Azoulay; Dimitrios Giakoustidis
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

5.  BH3-only protein bid participates in the Bcl-2 network in healthy liver cells.

Authors:  Hayato Hikita; Tetsuo Takehara; Takahiro Kodama; Satoshi Shimizu; Atsushi Hosui; Takuya Miyagi; Tomohide Tatsumi; Hisashi Ishida; Kazuyoshi Ohkawa; Wei Li; Tatsuya Kanto; Naoki Hiramatsu; Lothar Hennighausen; Xiao-Ming Yin; Norio Hayashi
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

Review 6.  Dysregulation of apoptosis in hepatocellular carcinoma cells.

Authors:  Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

7.  Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.

Authors:  Nicolas Charette; Christine De Saeger; Valérie Lannoy; Yves Horsmans; Isabelle Leclercq; Peter Stärkel
Journal:  Mol Cancer       Date:  2010-09-22       Impact factor: 27.401

8.  Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway.

Authors:  Deepak Bhatia; Roslin J Thoppil; Animesh Mandal; Karishma A Samtani; Altaf S Darvesh; Anupam Bishayee
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

9.  A novel benzothiazole derivative YLT322 induces apoptosis via the mitochondrial apoptosis pathway in vitro with anti-tumor activity in solid malignancies.

Authors:  Song Xuejiao; Xia Yong; Wang Ningyu; Zhang Lidan; Shi Xuanhong; Xu Youzhi; Ye Tinghong; Shi Yaojie; Zhu Yongxia; Yu Luoting
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

10.  A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase.

Authors:  Venturina Stagni; Simonetta Santini; Daniela Barilà
Journal:  Cancers (Basel)       Date:  2012-04-05       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.